Free Trial

Maestria Partners LLC Has $29.82 Million Stake in Brookfield Corporation (NYSE:BN)

Brookfield logo with Finance background

Maestria Partners LLC boosted its position in Brookfield Corporation (NYSE:BN - Free Report) by 9.6% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 569,019 shares of the company's stock after purchasing an additional 50,000 shares during the quarter. Brookfield comprises 12.6% of Maestria Partners LLC's investment portfolio, making the stock its biggest position. Maestria Partners LLC's holdings in Brookfield were worth $29,822,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Norges Bank bought a new position in shares of Brookfield during the 4th quarter valued at $973,591,000. Geode Capital Management LLC grew its holdings in shares of Brookfield by 32.0% during the 4th quarter. Geode Capital Management LLC now owns 7,960,098 shares of the company's stock valued at $460,489,000 after purchasing an additional 1,930,218 shares during the last quarter. Capital World Investors grew its holdings in shares of Brookfield by 3.1% during the 4th quarter. Capital World Investors now owns 59,020,303 shares of the company's stock valued at $3,390,786,000 after purchasing an additional 1,782,034 shares during the last quarter. Bessemer Group Inc. grew its holdings in shares of Brookfield by 51.9% during the 4th quarter. Bessemer Group Inc. now owns 4,839,267 shares of the company's stock valued at $278,016,000 after purchasing an additional 1,652,935 shares during the last quarter. Finally, FIL Ltd grew its holdings in shares of Brookfield by 8.8% during the 4th quarter. FIL Ltd now owns 20,354,516 shares of the company's stock valued at $1,169,912,000 after purchasing an additional 1,640,903 shares during the last quarter. 61.60% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on BN. Wall Street Zen lowered shares of Brookfield from a "hold" rating to a "sell" rating in a report on Saturday, July 12th. CIBC cut their price target on shares of Brookfield from $74.00 to $72.00 and set an "outperformer" rating on the stock in a report on Friday, May 9th. Royal Bank Of Canada began coverage on shares of Brookfield in a report on Wednesday, June 18th. They issued an "outperform" rating and a $81.00 price target on the stock. Morgan Stanley reissued an "overweight" rating on shares of Brookfield in a report on Monday, May 19th. Finally, TD Securities dropped their target price on shares of Brookfield from $77.00 to $74.00 and set a "buy" rating for the company in a research report on Monday, May 5th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and six have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $66.13.

Get Our Latest Analysis on Brookfield

Brookfield Stock Up 0.2%

NYSE BN traded up $0.16 during trading hours on Friday, reaching $67.61. 1,059,913 shares of the company's stock traded hands, compared to its average volume of 2,647,045. Brookfield Corporation has a 52-week low of $42.21 and a 52-week high of $68.75. The firm has a market cap of $111.47 billion, a PE ratio of 241.50 and a beta of 1.66. The firm has a 50-day simple moving average of $60.95 and a 200 day simple moving average of $57.09. The company has a debt-to-equity ratio of 1.49, a current ratio of 1.30 and a quick ratio of 1.18.

Brookfield (NYSE:BN - Get Free Report) last issued its earnings results on Thursday, May 8th. The company reported $0.98 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.08. The business had revenue of $1.37 billion during the quarter, compared to analysts' expectations of $1.36 billion. Brookfield had a net margin of 0.76% and a return on equity of 4.20%. Sell-side analysts anticipate that Brookfield Corporation will post 3.85 EPS for the current fiscal year.

Brookfield Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, June 30th. Stockholders of record on Friday, June 13th were paid a $0.09 dividend. The ex-dividend date of this dividend was Friday, June 13th. This represents a $0.36 dividend on an annualized basis and a dividend yield of 0.53%. Brookfield's dividend payout ratio is presently 128.57%.

About Brookfield

(Free Report)

Brookfield Corporation is an alternative asset manager and REIT/Real Estate Investment Manager firm focuses on real estate, renewable power, infrastructure and venture capital and private equity assets. It manages a range of public and private investment products and services for institutional and retail clients.

Featured Articles

Institutional Ownership by Quarter for Brookfield (NYSE:BN)

Should You Invest $1,000 in Brookfield Right Now?

Before you consider Brookfield, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Brookfield wasn't on the list.

While Brookfield currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines